Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis

A QuémardJ S Blanchard


The inhA gene has been recently shown to encode a common protein target for isoniazid and ethionamide action in Mycobacterium tuberculosis. In this paper, we demonstrate that the M. tuberculosis InhA protein catalyzes the NADH-specific reduction of 2-trans-enoyl-ACP, essential for fatty acid elongation. This enzyme preferentially reduces long-chain substrates (12-24 carbons), consistent with its involvement in mycolic acid biosynthesis. Steady-state kinetic studies showed that the two substrates bind to InhA via a sequential kinetic mechanism, with the preferred ordered addition of NADH and the enoyl substrate. The chemical mechanism involves stereospecific hydride transfer of the 4S hydrogen of NADH to the C3 position of the 2-trans-enoyl substrate, followed by protonation at C2 of an enzyme-stabilized enolate intermediate. Kinetic and microcalorimetric analysis demonstrates that the binding of NADH to the S94A mutant InhA, known to confer resistance to both isoniazid and ethionamide, is altered. This difference can account for the isoniazid-resistance phenotype, with the formation of a binary InhA-NADH complex required for drug binding. Isoniazid binding to either the wild-type or S94A mutant InhA could not be detected by tit...Continue Reading


Jan 1, 1979·Methods in Enzymology·W W Cleland
Feb 6, 1970·Biochemical and Biophysical Research Communications·S MatsumuraK Bloch
Feb 25, 1993·The New England Journal of Medicine·T R FriedenS W Dooley
May 1, 1963·The Biochemical Journal·K P GOPINATHANT RAMAKRISHNAN

❮ Previous
Next ❯


Jan 20, 2009·Cellular and Molecular Life Sciences : CMLS·R P Massengo-Tiassé, J E Cronan
Jul 12, 1996·Biochimica Et Biophysica Acta·C O Rock, J E Cronan
Aug 1, 1996·Molecular Aspects of Medicine·M J Colston
Jan 1, 1996·Research in Microbiology·J C Sacchettini, J S Blanchard
Jun 25, 2002·Journal of Molecular Biology·Martin Cohen-GonsaudAnnaïk Quemard
Oct 10, 2001·Progress in Lipid Research·R J HeathC O Rock
Nov 26, 1998·Progress in Lipid Research·C E BarryY Yuan
Jan 1, 1999·Bioorganic & Medicinal Chemistry Letters·M C DavisA R Martin
Jul 8, 2000·Microbes and Infection·R A Slayden, C E Barry
Dec 17, 2011·Expert Reviews in Molecular Medicine·Ashwani KumarAdrie J C Steyn
Jan 16, 2008·Accounts of Chemical Research·Hao Lu, Peter J Tonge
Oct 25, 2011·Biochemistry·Janine G BorgaroPeter J Tonge
Jul 31, 2013·Journal of Chemical Information and Modeling·Ivani PauliOsmar Norberto de Souza
Jun 6, 2009·Nature·Liangcai GuDavid H Sherman
May 2, 2006·Nature Structural & Molecular Biology·Argyrides ArgyrouJohn S Blanchard
Jul 4, 1998·Natural Product Reports·B J Rawlings
Dec 19, 2009·The Journal of Biological Chemistry·Carl A MachuttaPeter J Tonge
Sep 25, 2010·The Journal of Biological Chemistry·Shazia KhanVinay Kumar Nandicoori
Jun 1, 2012·The Journal of Biological Chemistry·Makoto NikiSohkichi Matsumoto
Oct 11, 2005·The Journal of Biological Chemistry·Loretha Carlisle-MoorePeter J Tonge
Dec 19, 2008·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Farahnoosh DoustdarAli Akbar Velayati
Oct 30, 2012·Bioinformatics·Benjamin MergetChristoph A Sotriffer
Mar 12, 2011·The Journal of Antimicrobial Chemotherapy·Nina LiuPeter J Tonge
Jun 7, 2006·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Jun SaitoYasuo Takeuchi
Mar 24, 2012·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Tae-O KimYong-Seok Heo
Jan 25, 2002·Annals of the New York Academy of Sciences·M Caws, F A Drobniewski
Jul 28, 2006·Antimicrobial Agents and Chemotherapy·Sho TakahataShigeru Hoshiko
Jun 16, 2001·Antimicrobial Agents and Chemotherapy·A S LeeS Y Wong
Aug 17, 2002·Antimicrobial Agents and Chemotherapy·Vanja M BulatovicFrank Rusnak
Dec 25, 2003·Antimicrobial Agents and Chemotherapy·Stéphanie Ducasse-CabanotAnnaïk Quémard
Apr 24, 2004·Antimicrobial Agents and Chemotherapy·Losee L LingDonald T Moir

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.